Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling.

Schimmack S, Taylor A, Lawrence B, Schmitz-Winnenthal H, Fischer L, B?chler MW, Modlin IM, Kidd M, Tang LH. Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling. Tumour Biol. 2015 Jan; 36(1):399-408.

View in: PubMed

subject areas

Cell Line, Tumor
Cell Proliferation
DNA Copy Number Variations
Gene Expression
Humans
Imidazoles
Liver Neoplasms
Neuroendocrine Tumors
Pancreas
Pancreatic Neoplasms
Phosphorylation
Protein Processing, Post-Translational
Quinolines
RNA, Messenger
Signal Transduction
Stathmin

authors with profiles

Andrew Taylor, Ph.D.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support